Table 2 Blood tests and the three outcome variables according to gender
|  | Overall (N = 397) | Gender | P | |
|---|---|---|---|---|
Men (n = 178, 44.8%) | Women (n = 219, 55.2%) | |||
Blood tests | ||||
 FBG (in mg/dl) | 96 (± 30.3) | 102.70 (± 41.639) | 91.53 (± 14.325) | 0.000* |
 2 h OGTT (in mg/dl) | 111 (± 64.8) | 125.74 (± 85.688) | 99.70 (± 36.985) | 0.000* |
 TC (in mg/dl) | 198 (± 41.2) | 189.71 (± 42.258) | 205.20 (± 39.196) | 0.000* |
 TG (in mg/dl) | 139 (± 87.8) | 160.97 (± 98.770) | 122.65 (± 73.715) | 0.000* |
 HDL-C (in mg/dl) | 48 (± 13.6) | 41.56 (± 11.083) | 54.04 (± 12.954) | 0.000 * |
 LDL-C (in mg/dl) | 123 (± 36.9) | 117.39 (± 39.656) | 127.71 (± 33.955) | 0.006* |
 SBP (in mmHg) | 121 (± 23.4) | 125.48 (± 25.957) | 117.65 (± 20.610) | 0.001* |
 DBP (in mmHg) | 77 (± 15.3) | 80.29 (± 17.013) | 75.49 (± 13.547) | 0.003* |
 FINDRISC score | 10 (± 4.2) | 11.07 (± 4.685) | 10.79 (± 3.958) | 0.528 |
Outcomes | ||||
 UT2DM | 30 (7.6%) | 22 (12.4%) | 8 (3.7%) | 0.001* |
 Prediabetes | 91 (22.9%) | 53 (29.8%) | 38 (17.4%) | 0.003* |
 MS | 142 (35.8%) | 85 (47.7%) | 57 (26%) | 0.000* |